Schisandrol A Mitigated Voriconazole‐induced Liver Injury in Mice Through Regulation of Farnesoid X Receptor‐mediated Bile Acid Metabolism
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202402769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Fangxu Qin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan, China. Hauptthemen laut MEDLINE: Bile Acids and Salts, Chemical and Drug Induced Liver Injury, Cyclooctanes, Lignans. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Bureau of Health of zhongshan Municipality, Guangdong Yiyang Healthcare Charity Foundation, Zhongshan Science and Technology Bureau.
Abstract (Originalsprache)
Schisandrol A has been previously used to mitigate hepatotoxicity. However, the effects of schisandrol A on voriconazole‐induced hepatic injury have not been investigated. In this study, we aimed to explore the effects of schisandrol A on voriconazole‐induced hepatic injury in mice, as well as to elucidate the underlying mechanism. Mice were continuously treated with voriconazole with or without schisandrol A administration. Acetaminophen was used as a positive control to induce liver damage. Hematological, histological, and gene analyses were conducted, and the therapeutic target of schisandrol A was verified. Our results showed that voriconazole‐induced hepatic injury was similar to that induced by acetaminophen. Importantly, schisandrol A alleviated voriconazole‐induced hepatic steatosis, cell death, inflammation, and fibrosis. Schisandrol A reduced oxidative damage and inflammation in the liver. Furthermore, schisandrol A reduced total bile acid, cholesterol, and triglyceride levels in the liver and serum. The expression of farnesoid X receptor (FXR), small heterodimer partner, cytochrome P450 (CYP) 7A1, and sterol 12α‐hydroxylase in the liver was altered by schisandrol A treatment. The binding of schisandrol A to FXR was verified by the cellular thermal shift assay and molecular docking. In conclusion, these findings suggested the favorable effects of schisandrol A against voriconazole‐induced hepatotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan, China.
ORCID-Profile: Xiongquan Qiu
Förderung
- Bureau of Health of zhongshan Municipality
- Guangdong Yiyang Healthcare Charity Foundation
- Zhongshan Science and Technology Bureau
Zitieren
APA
Qin, F., Tian, L., Wang, Z., & Qiu, X. (2025). Schisandrol A Mitigated Voriconazole‐induced Liver Injury in Mice Through Regulation of Farnesoid X Receptor‐mediated Bile Acid Metabolism. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402769
Vancouver
Qin F, Tian L, Wang Z, Qiu X. Schisandrol A Mitigated Voriconazole‐induced Liver Injury in Mice Through Regulation of Farnesoid X Receptor‐mediated Bile Acid Metabolism. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402769
BibTeX
@article{Qin2025,
author = {Qin, Fangxu and Tian, Lifeng and Wang, Zhien and Qiu, Xiongquan},
title = {Schisandrol A Mitigated Voriconazole‐induced Liver Injury in Mice Through Regulation of Farnesoid X Receptor‐mediated Bile Acid Metabolism},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202402769}
}
EUVIMED